Big Pharma Incentives Are Out of Whack: Why We Need an X-Prize for Drugs

The entire U.S. patent system needs serious repair, but the most broken thing about it is the way we patent prescription drugs. Federal and state governments spend billions of dollars on basic medical research, and the resulting science winds up informing (at least indirectly) the development of blockbuster pharmaceuticals.